This paper describes the technology and early clinical development of the CAR T NKR-2 platform and elucidates its fundamental differences with classical CAR-T…

Eli Lilly

Sanofi, Voluntis ally to pilot diabetes management app

Lilly, Chi-Med cancer drug hits phase 3 goals, eyes China NDA

Chutes & Ladders: Novo’s North American head exits after losing the race for CEO

Accera fails phase 3 Alzheimer’s trial, denting energy theory

Roche starts second Alzheimer’s phase 3 of anti-Abeta drug